Ongoing Disclosure Notices

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
EBOS Group Limited
Date this disclosure made:
9-Apr-19
Date of last disclosure:
26-Mar-19
Director or senior manager giving disclosure
Full name(s):
Mark Waller
Name of listed issuer:
EBOS Group Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary
Nature of the affected relevant interest(s):
Issue of shares pursuant to dividend
reinvestment plan
For that relevant interest-
Number held in class before acquisition or disposal:
500,265
Number held in class after acquisition or disposal:
506,692
Current registered holder(s):
Mark Brendon Waller & Angela
Laura Waller
Registered holder(s) once transfers are registered:
Mark Brendon Waller & Angela
Laura Waller
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1
Details of transactions requiring disclosure-
Date of transaction:5-Apr-19
Nature of transaction:
Issue of shares pursuant to dividend
reinvestment plan

Name of any other party or parties to the transaction (if known):
N/A
The consideration, expressed in New Zealand dollars, paid or received for the acquisition
or disposal. If the consideration was not in cash and cannot be readily by converted into a
cash value, describe the consideration:
$135,738.24
Number of financial products to which the transaction related: 6,427 ordinary shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:Ordinary shares
Nature of relevant interest:
Mark Brendon Waller & John
Matthew Cullity as trustees of the
EBOS Staff Share Plan
For that relevant interest,-
Number held in class:
71,592 ordinary shares
Current registered holder(s):
Mark Brendon Waller & John
Matthew Cullity as trustees of the
EBOS Staff Share Plan
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
Certification
I certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons
for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
9-Apr-19
Name and title of authorised person:
Janelle Cain, General Counsel,
EBOS Group Limited

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
EBOS Group Limited
Date this disclosure made:
9-Apr-19
Date of last disclosure:
9-Nov-15
Director or senior manager giving disclosure
Full name(s):
Sarah Ottrey
Name of listed issuer:
EBOS Group Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary
Nature of the affected relevant interest(s):
Issue of shares pursuant to dividend
reinvestment plan
For that relevant interest-
Number held in class before acquisition or disposal:
8079 ordinary shares
Number held in class after acquisition or disposal:
8176 ordinary shares
Current registered holder(s):
Sarah Christine Ottrey & Peter
Calder Groves
Registered holder(s) once transfers are registered:
Sarah Christine Ottrey & Peter
Calder Groves
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1
Details of transactions requiring disclosure-
Date of transaction:5-Apr-19

Nature of transaction:
Issue of shares pursuant to dividend
reinvestment plan
Name of any other party or parties to the transaction (if known):N/A
The consideration, expressed in New Zealand dollars, paid or received for the acquisition
or disposal. If the consideration was not in cash and cannot be readily by converted into a
cash value, describe the consideration:
$2,048.64
Number of financial products to which the transaction related: 97 ordinary shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:Ordinary
Nature of relevant interest:
Beneficial interest
For that relevant interest,-
Number held in class:3050 ordinary shares
Current registered holder(s):
FNZ Nominees Limited which holds
shares on behalf of The Phil Ingham
Family Trust
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
Certification
I certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons
for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
9-Apr-19
Name and title of authorised person:
Janelle Cain, General Counsel,
EBOS Group Limited

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
EBOS Group Limited
Date this disclosure made:
9-Apr-19
Date of last disclosure:
22-Sep-17
Director or senior manager giving disclosure
Full name(s):
Sean Duggan
Name of listed issuer:
EBOS Group Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Chief Executive Officer, Animal Care &
Consumer Brands
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary shares in EBOS Group Limited
Nature of the affected relevant interest(s):
Issue of shares pursuant to dividend
reinvestment plan
For that relevant interest-
Number held in class before acquisition or disposal:
306 ordinary shares
Number held in class after acquisition or disposal:
310 ordinary shares
Current registered holder(s):
Sean Duggan
Registered holder(s) once transfers are registered:
Sean Duggan
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
N/A
Maturity date of the derivative (if any):
N/A
Expiry date of the derivative(if any):
N/A
The price specified in the terms of the derivative (if any):
N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products: N/A
For that derivative,-
Parties to the derivative:
N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:N/A
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1
Details of transactions requiring disclosure-
Date of transaction:5-Apr-19
Nature of transaction:
Issue of shares pursuant to dividend
reinvestment plan
Name of any other party or parties to the transaction (if known):N/A
The consideration, expressed in New Zealand dollars, paid or received for the acquisition
or disposal. If the consideration was not in cash and cannot be readily by converted into a
cash value, describe the consideration:
$84.48
Number of financial products to which the transaction related: 4 ordinary shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—

Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:Ordinary shares
Nature of relevant interest:
1. Registered holder - 2016 long term
incentive plan
2. Registered holder - 2017 long term
incentive plan
For that relevant interest,-
Number held in class:
1. 45,000 ordinary shares
2. 50,000 ordinary shares
Current registered holder(s):Sean Duggan
For a derivative relevant interest,-
Type of derivative:N/A
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
Certification
I certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons
for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
9-Apr-19
Name and title of authorised person:
Janelle Cain, General Counsel, EBOS Group
Limited

---

Appendix 3Y
Change of Director’s Interest Notice



+ See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Rule 3.19A.2
Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11

Name of entity EBOS Group Limited
ABN N/A

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the
director for the purposes of section 205G of the Corporations Act.

Name of Director Mark Waller
Date of last notice 26 March 2019

Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed
in this part.

Direct or indirect interest
Direct

Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.


Date of change
5 April 2019
No. of securities held prior to change
 Mark Brendon Waller & John Matthew
Cullity as trustees of the EBOS Staff
Share Plan: 71,592 ordinary shares
 Mark Brendon Waller & Angela Laura
Waller: 500,265 ordinary shares

Class
Ordinary shares
Number acquired
6,427
Number disposed
Nil
Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation

NZ$135,738.24

Appendix 3Y
Change of Director’s Interest Notice



+ See chapter 19 for defined terms.

Appendix 3Y Page 2 01/01/2011

No. of securities held after change
 Share Plan holding: 71,592 ordinary
shares
 Mark Brendon Waller & Angela Laura
Waller: 506,692 ordinary shares

Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
Issue of shares pursuant to dividend
reinvestment plan

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed
in this part.

Detail of contract

Nature of interest



Name of registered holder
(if issued securities)


Date of change

No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in relation
to which the interest has changed


Interest acquired

Interest disposed

Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation


Interest after change


Part 3 –
+
Closed period

Were the interests in the securities or contracts detailed
above traded during a
+
closed period where prior written
clearance was required?
No.
If so, was prior written clearance provided to allow the trade
to proceed during this period?

If prior written clearance was provided, on what date was this
provided?

Appendix 3Y
Change of Director’s Interest Notice



+ See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Rule 3.19A.2
Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11

Name of entity EBOS Group Limited
ABN N/A

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the
director for the purposes of section 205G of the Corporations Act.

Name of Director Sarah Ottrey
Date of last notice 9 November 2015

Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed
in this part.

Direct or indirect interest
Direct
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.


Date of change
5 April 2019
No. of securities held prior to change
 8,079 ordinary shares /directly held
 3,050 ordinary shares /beneficial interest
Class
Ordinary shares
Number acquired
97 ordinary shares
Number disposed
Nil
Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation

$2,048.64
No. of securities held after change
 Directly: 8,176 ordinary shares
 Indirectly: 3,050 ordinary shares

Appendix 3Y
Change of Director’s Interest Notice



+ See chapter 19 for defined terms.

Appendix 3Y Page 2 01/01/2011

Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
Issue of shares pursuant to dividend
reinvestment plan

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed
in this part.

Detail of contract

Nature of interest



Name of registered holder
(if issued securities)


Date of change

No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in relation
to which the interest has changed


Interest acquired

Interest disposed

Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation


Interest after change


Part 3 –
+
Closed period

Were the interests in the securities or contracts detailed
above traded during a
+
closed period where prior written
clearance was required?
No.
If so, was prior written clearance provided to allow the trade
to proceed during this period?

If prior written clearance was provided, on what date was this
provided?